Detecting Systematic Data Manipulation in Diagnostic Reporting

This case study highlights how Techsurance detected systematic manipulation in diagnostic reporting through forensic analysis of repeated biochemical and hematological values across multiple patient reports from a diagnostic center in southern India. By identifying statistically improbable similarities in medical test results, Techsurance successfully prevented the onboarding and processing of potentially fraudulent medical cases, protecting insurers from high-risk claim exposure.

Key Outcomes at a Glance

Suggested high-risk diagnostic discrepancies aligned with insurer review outcomes

0 %

Manipulated diagnostic reports identified through forensic variance analysis

₹ 1 Cr+

Fraudulent diagnostic-based applications processed into insurer portfolios

The Challenge (The Problem)

In the healthcare and insurance sectors, the authenticity of medical diagnostic reports is critical for both patient care and claims processing. During a routine audit of reports from one of the diagnostic centers in the southern part of India, suspicious patterns were identified that suggested the reports were not reflective of genuine, individual clinical tests.

Key Outcomes at a Glance

Improbable Data Consistency

Multiple test reports for different patients contained identical “derived range values” across various applications.

Biological Statistical Anomalies

It is medically and statistically highly improbable for different individuals to consistently produce identical results in complex biochemical and hematological panels.

Suspected Duplication

The findings pointed toward systematic report manipulation or duplication rather than independent patient testing.

The Discovery (The Evidence)

Through a side-by-side comparison of patient files, several mirrored data points were identified

Lipid Profile

Patients with different demographics (e.g., a 37-year-old male and a 35-year-old female) showed identical Total Cholesterol (180 mg/dL) and Triglycerides (102 mg/dL).

Liver Function

Multiple patients showed identical Indirect Bilirubin (0.50 mg/dL), Total Protein (7.1 gm/dL), and Globulin (3.2 gm/dL).

Hematology (CBC)

Identical values were found for MCH (29.1 pg) and MCHC (32.0 gm/dL) across unrelated patient files.

Biochemistry

Random Blood Glucose and Total Cholesterol values were perfectly matched (e.g., 85 mg/dL and 167 mg/dL) across different SID numbers and collection dates.

The Techsurance Solution

Using advanced data auditing and forensic verification, Techsurance implemented a multi-layered detection strategy:

Cross-Application Data Matching

Reports across different submissions were compared to identify repeating numerical signatures.

Biological Variance Auditing

The system flagged reports where complex derived values lacked the natural biological variance expected in human test results.

Diagnostic Integrity Scoring

Diagnostic centers were evaluated through historical data analysis to ensure their reporting aligned with accepted clinical standards.

The Result

Risk Mitigation

Successfully identified a systematic failure in reporting integrity at one of the diagnostic centers in the southern part of India.

Fraud Prevention

Prevented the processing of potentially fraudulent claims based on manipulated medical data.

Operational Security

Provided actionable evidence that enabled the client to blacklist non-compliant diagnostic partners, ensuring only high-integrity medical data is used for underwriting and claims decisions.

Conclusion

When “identical” becomes “impossible”, Techsurance delivers the forensic oversight needed to protect the integrity of the diagnostic ecosystem.

This case study demonstrates how identifying identical derived values in medical reports can uncover large-scale diagnostic fraud, helping healthcare providers and insurers rely only on authentic, verified patient data.

Protect Your Portfolio with Techsurance's Eagle Eye

Join leading insurers who trust Techsurance’s expert underwriting team to detect fraud, ensure compliance, and deliver operational excellence across every policy decision.